Retatrutide 60mg 5x12mg ZPHC
Troynoy agonist receptors GLP-1, gastrointestinalP and GCGR
Description
Retatrutid - is innovatsionnyy agonist (stimulyator) receptors glyukagonopodobnogo peptida-1 (GLP-1), glyukozozavisimogo insulinotropnogo polipeptida (gastrointestinalP) and receptors glucagon. Studies pokazali, which u vzroslykh, stradayushchikh ozhireniem ili izbytochnym vesom bez soputstvuyushchego diabeta, product privodit k reduction mass body more chem in 24% due to god.
Specifications
Retatrutid – is agonist receptors GLP-1, gastrointestinalP and retseptora glucagon. Eto oznachaet, which in svyazyvaetsya with etimi retseptorami and aktiviruet ikh, which privodit k ryadu metabolic effects:
1. Reguliruet production insulin, reducing level glucose.
2. Sderzhivaet appetite, pomogaya kontrolirovat intake calories.
3. Szhigaet fat and reduces level plokhogo cholesterol
4. Uskoryaet metabolism Effektivnost and bezopasnost: Retratrutid is naibolee effektivnym iz when-libo razrabotannykh peptidov for weight loss. Imeet menshiy risk adverse effects and may stat alternativnym preparatom for tekh, kto not perenosit pobochnye effekty Semaglutida. Polzovateli Retatrutida teryayut in vese in 60% bolshe, chem in use Semaglutida.
Glavnoe preimushchestvo:
U other preparatov k kontsu goda tempy padayut in 1.5–2 times, a u retatrutida:
- Cherez 48 weeks in vse eshche reduces ves in 0.5% in per week — is vyshe, chem startovye pokazateli semaglutida!
- Net rezkogo «plato»: vy prodolzhaete khudet, a not topchetes in mest
Composition / properties
Tip:Inektsionnye products
Manufacturer:ZPHC
Active ingredient:Retatrutide
Fasovka: 5 po 12mg
Reviews
Leave a review